Trial Intensifies Concerns About Safety of Vytorin »

Posted By 899webdesign 1 year, 4 months ago in Science & Technology
Prop it 3 Drop it

In a clinical trial, the cholesterol -lowering drug Vytorin did not help people with heart-valve disease avoid further heart problems but did appear to increase their risk of cancer , scientists reported Monday.

Read Full Story at nytimes.com »

971 Views Share Story 0 Comments Report

RSSPropping this Article (3)

Submit a Story

Advertisement

Dropping This Article

No one has dropped this story.

Groups Watching This

No groups are watching this story. Why not share it with your groups?